Andean Precious Metals (CVE:APM) Stock Price Down 9.6% - Should You Sell?

Shares of Andean Precious Metals Corp. (CVE:APM - Get Free Report) traded down 9.6% on Tuesday . The stock traded as low as C$1.12 and last traded at C$1.13. 515,749 shares changed hands during trading, an increase of 167% from the average session volume of 193,385 shares. The stock had previously closed at C$1.25.

Wall Street Analyst Weigh In

Separately, Desjardins upgraded Andean Precious Metals to a "moderate buy" rating in a research report on Thursday, October 31st.

Andean Precious Metals Stock Down 10.4 %

The firm has a market cap of C$167.28 million, a P/E ratio of 2.95 and a beta of 1.22. The business has a fifty day simple moving average of C$1.43 and a 200-day simple moving average of C$1.25.

Insider Buying and Selling

In related news, insider 2176423 Ontario Ltd. bought 213,800 shares of the business's stock in a transaction dated Wednesday, October 2nd. The shares were purchased at an average cost of C$1.38 per share, with a total value of C$294,530.88. Insiders acquired a total of 306,200 shares of company stock worth $432,953 in the last three months. 69.37% of the stock is owned by corporate insiders.

About Andean Precious Metals

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.